Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Key Highlights
- ➤$0.14-per-share dividend, totaling approximately $8.0 million, expected December 9
- ➤Israel Tax Authority extends ruling enabling eligible Nasdaq holders reduced withholding rates
- ➤25% initially withheld; qualifying Treaty State shareholders may reclaim the difference
- ➤Documentation for tax refunds must reach IBI Trust Management by January 11, 2027
REHOVOT, Israel and HOBOKEN, N.J., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the “Company”) (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced today that it has obtained an extension of the previously granted tax ruling (the “Ruling”) from the Israel Tax Authority (the “ITA”) with respect to the cash dividend of $0.14 (approximately NIS 0.45) per share on the Company’s ordinary shares (totaling approximately $8.0 million) announced on November 9, 2026 (the “Dividend”), expected to be paid on December 9, 2026 (the “Payment Date”), to shareholders of record at the close of business on November 19, 2026 (the “Record Date”).
As a result of the Ruling, shareholders who hold Company shares as of the Record Date that trade such shares on the Nasdaq Stock Market (“Nasdaq Shareholders”) and who are residents of a country with which Israel has a tax treaty (“Treaty State”), may be eligible for a reduced Israeli withholding tax rate (a “Reduced Withholding Tax Rate”) on their share of the Dividend (the “Nasdaq Dividend”), in comparison to the generally applicable Israeli withholding tax rate, subject to certain terms and conditions as generally set forth below. In addition, Nasdaq Shareholders that are Israeli corporate shareholders may be eligible for an exemption from Israeli withholding tax, subject to the terms and conditions set forth in the Ruling and generally described below.
Get started
Create a free account to read the full story.
